Dibenzocyclooctadiene lingnans: A class of novel inhibitors of P-glycoprotein

Cancer Chemotherapy and Pharmacology

Volumn 58, Issue 1, 2006, Pages 99-106

  Pan, Qiangrong ^a   Lu, Qinghua ^a   Zhang, Kun ^a   Hu, Xun ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cancer; Multidrug resistance; P glycoprotein; Schisandrin A; Schisandrin B; Schisandrol A; Schisandrol B; Schisantherin A

Indexed keywords

AZIDOPINE; BENZOIC ACID; DAUNORUBICIN; DIBENZOCYCLOOCTADIENE LIGNAN DERIVATIVE; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; GOMISIN A; HYDROXYL GROUP; MULTIDRUG RESISTANCE PROTEIN; NATURAL PRODUCT; PACLITAXEL; SCHIZANDRIN A; SCHIZANDRIN B; SCHIZANDROL A; SCHIZANTHERIN A; UNCLASSIFIED DRUG; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN K 562; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG PROTEIN BINDING; ESTERIFICATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IC 50; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; SCHISANDRACEAE; STRUCTURE ACTIVITY RELATION;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOCTANES; DAUNORUBICIN; DIOXOLES; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; INHIBITORY CONCENTRATION 50; K562 CELLS; LIGNANS; P-GLYCOPROTEIN; PACLITAXEL; POLYCYCLIC COMPOUNDS; VINCRISTINE;

EID: 33645976829     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0133-1     Document Type: Article

References (14)

1. Gottesman MM, Tito F, Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 1:48-58
2. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan II, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361-398
3. Schinke AH, Jonker JW (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliver Rev 55:3-29
4. Rajesh K, Lawrence DM (2000) Multidrug resistance in cancer mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11:265-283
5. Teodori E, Dei S, Scapecchi S, Gualtieri F (2003) The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Farmaco 57:385-415
6. Schinkel AH, Jonker JW (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliver Rev 55:3-29
7. Hu X, Yang H, Pan QR, Zheng S (1995) Does P-glycoprotein play a pivotal role in the drug resistance of an MDR variant, K562/Dox? Chemotherapy 41:296-305
8. Fairchild CR, Ivy SP, Kao SCS, Wang PJ, Rosen N, Isreal MA, Melera PW, Goldsmith ME (1987) Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res 47:5141-5148
9. Zhang XH, Zhang FY, Ji XJ, Li ZY (1994) Vincristine-resistant human KB cell line and mechanism of multidrug resistance. Yao Xue Xue Bao 29:246-251
10. Wang Y, Cao J, Zeng S (2004) Establishment of a P-glycoprotein substrate screening model and its preliminary application. World J Gastroenterol 10:1365-1368
11. Hyafil F, Vergely C, Du Vignaud P, Grand-Perret T (1993) In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res 53:4595-4602
12. Ip SP, Ko KM (1996) The crucial antioxidant action of Sch B in protecting against carbon tetrachloride hepatotoxicity in mice: a comparative study with butylated hydroxytoluene. Biochem Pharmacol 52:1687-1693
13. Ip SP, Poon MK, Che CT, Ng KH, Kong YC, Ko KM (1996) Schisandrin B protects against carbon tetrachloride toxicity by enhancing the mitochondrial glutathione redox status in mouse liver. Free Radic Biol Med 21:709-712
14. Hanck JL, Burgos RA, Ahumanda F (1999) Schisandra chinensis(Turcz). Bail Fitoterapia 70:451-471